Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus.

Emerging microbes & infections - 1 Dec 2024

Kim Jae-Deog, Lee Ah-Ra, Moon Dah-Hyun, Chung Young-Uk, Hong Su-Yeon, Cho Hyo Je, Kang Tae Hyun, Jang Yo Han, Sohn Myung Hyun, Seong Baik-Lin, Seo Sang-Uk

Abstract excerpt

Japanese encephalitis (JE), caused by the Japanese encephalitis virus (JEV), is a highly threatening disease with no specific treatment. Fortunately, the development of vaccines has enabled effective defense against JE. However, re-emerging genotype V (GV) JEV poses a challenge as current vaccines are genotype III (GIII)-based and provide suboptimal protection. Given the isolation of GV JEVs from Malaysia, China,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Antigens, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholera Toxin

Share to Encephalitis, Japanese

Share to Encephalitis Virus, Japanese

Share to Genotype

Share to Mice, Inbred BALB C

Source

Open in PubMed Open full text

Identifiers

PMID: 38618740
DOI: 10.1080/22221751.2024.2343910
PMCID: PMC11060017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus.PMID 38618740Read ↗

The hidden threats posed by Japanese encephalitis virus genotype V.Semantic proximity Read ↗

Study on the Protective Efficacy of the Japanese Encephalitis Live Attenuated Vaccine SA14-14-2 Against Newly Isolated Genotype I Japanese Encephalitis Viruses.Semantic proximity Read ↗

Emerging Japanese Encephalitis Virus Genotype V in Republic of Korea.Semantic proximity Read ↗

Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategiesSemantic proximity Read ↗

Virulence and Cross-Protection Conferred by an Attenuated Genotype I-Based Chimeric Japanese Encephalitis Virus Strain Harboring the E Protein of Genotype V in Mice.Semantic proximity Read ↗

Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.Semantic proximity Read ↗

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.Semantic proximity Read ↗

Partial cross-protection between Japanese encephalitis virus genotype I and III in miceSemantic proximity Read ↗

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Semantic proximity Read ↗

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.Semantic proximity Read ↗

Characterization of genotype V Japanese encephalitis virus isolates from Republic of Korea.Semantic proximity Read ↗

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.